Jack Bendheim Sells 3,520 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 3,520 shares of the company’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $40.06, for a total value of $141,011.20. Following the completion of the transaction, the chief executive officer directly owned 46,240 shares of the company’s stock, valued at approximately $1,852,374.40. The trade was a 7.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Jack Bendheim also recently made the following trade(s):

• On Tuesday, December 9th, Jack Bendheim sold 1,288 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.19, for a total value of $51,764.72.
• On Wednesday, December 3rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.77, for a total transaction of $143,510.40.
• On Tuesday, November 25th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.93, for a total transaction of $309,267.20.
• On Wednesday, November 26th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.02, for a total value of $232,425.60.
• On Monday, November 17th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The shares were sold at an average price of $44.56, for a total value of $235,276.80.
• On Thursday, November 13th, Jack Bendheim sold 8,801 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.47, for a total transaction of $391,380.47.
• On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.23, for a total transaction of $974,073.28.
• On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.29, for a total transaction of $1,734,742.87.
• On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $42.86, for a total transaction of $150,867.20.
• On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.10, for a total value of $151,712.00.

Phibro Animal Health Trading Up 4.3%

Shares of Phibro Animal Health stock traded up $1.63 on Wednesday, hitting $39.91. 282,957 shares of the company’s stock traded hands, compared to its average volume of 280,482. The company has a fifty day moving average of $41.18 and a two-hundred day moving average of $34.31. Phibro Animal Health Corporation has a one year low of $16.16 and a one year high of $46.42. The company has a market capitalization of $1.62 billion, a price-to-earnings ratio of 24.04, a price-to-earnings-growth ratio of 1.14 and a beta of 0.77. The company has a debt-to-equity ratio of 2.32, a current ratio of 3.09 and a quick ratio of 1.35.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.15. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.The business had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. As a group, sell-side analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 17th. Investors of record on Wednesday, November 26th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, November 26th. This represents a $0.48 annualized dividend and a yield of 1.2%. Phibro Animal Health’s dividend payout ratio is currently 28.92%.

Institutional Investors Weigh In On Phibro Animal Health

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in shares of Phibro Animal Health by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company’s stock worth $32,500,000 after purchasing an additional 6,784 shares during the last quarter. Acadian Asset Management LLC increased its position in Phibro Animal Health by 0.5% in the first quarter. Acadian Asset Management LLC now owns 782,939 shares of the company’s stock worth $16,713,000 after buying an additional 4,144 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Phibro Animal Health by 1.4% in the second quarter. Geode Capital Management LLC now owns 554,927 shares of the company’s stock valued at $14,175,000 after buying an additional 7,841 shares during the period. Nuveen LLC bought a new position in shares of Phibro Animal Health during the 1st quarter worth $10,312,000. Finally, Invesco Ltd. increased its holdings in Phibro Animal Health by 92.3% in the 1st quarter. Invesco Ltd. now owns 387,739 shares of the company’s stock worth $8,282,000 after acquiring an additional 186,087 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on PAHC shares. Weiss Ratings restated a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday. Bank of America raised their target price on Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a research note on Friday, August 29th. Zacks Research lowered Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Morgan Stanley set a $34.00 price target on Phibro Animal Health in a report on Thursday, August 28th. Finally, JPMorgan Chase & Co. boosted their price objective on Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a report on Friday, November 7th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Phibro Animal Health has a consensus rating of “Hold” and a consensus price target of $31.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.